An older study by Clark et al. also showed that SCC tumors treated with imiquimod contained decreased percentages of Treg cells (from 41% to 31%, which resulted from a marked influx of non-Treg cells into the tumor, most of which were cytotoxic CD8+ T-cells). This evidence concerns the gene CD8A and neoplasm.